Neurovalens Secures FDA Clearance for Innovative PTSD Therapy Device

Neurovalens, a Northern Irish firm, has extended its FDA approvals by gaining clearance for a new device aimed at treating PTSD. The company has previously received FDA authorization for its technologies addressing insomnia, anxiety, and weight management.